These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16546281)

  • 1. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry.
    Tanderup K; Christensen JJ; Granfeldt J; Lindegaard JC
    Radiother Oncol; 2006 Apr; 79(1):87-93. PubMed ID: 16546281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
    Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids.
    Mourtada F; Gifford KA; Berner PA; Horton JL; Price MJ; Lawyer AA; Eifel PJ
    Med Dosim; 2007; 32(3):181-7. PubMed ID: 17707197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions.
    Wulf J; Popp K; Oppitz U; Baier K; Flentje M
    Strahlenther Onkol; 2004 Apr; 180(4):216-24. PubMed ID: 15057432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer.
    De Leeuw AA; Moerland MA; Nomden C; Tersteeg RH; Roesink JM; Jürgenliemk-Schulz IM
    Radiother Oncol; 2009 Nov; 93(2):341-6. PubMed ID: 19515443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectum dose analysis employing a multi-purpose brachytherapy phantom.
    Huh H; Kim W; Loh JJ; Lee S; Kim CY; Lee S; Shin D; Shin D; Cho S; Jang J; Lim S; Cho KH; Kwon S; Kim S
    Jpn J Clin Oncol; 2007 May; 37(5):391-8. PubMed ID: 17538010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
    Tan LT; Coles CE; Hart C; Tait E
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rectal shielding for a Selectron-ring applicator system (HDR- and LDR-afterloading)].
    Hetzel H; Kamleitner H; McCoy M; Frommhold H
    Strahlenther Onkol; 1987 Dec; 163(12):782-6. PubMed ID: 3424077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy.
    Andersen CE; Nielsen SK; Lindegaard JC; Tanderup K
    Med Phys; 2009 Nov; 36(11):5033-43. PubMed ID: 19994514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transit dose contributions to intracavitary and interstitial PDR brachytherapy treatments.
    Menon GV; Carlone MC; Sloboda RS
    Phys Med Biol; 2008 Jul; 53(13):3447-62. PubMed ID: 18547912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations.
    Waldhäusl C; Wambersie A; Pötter R; Georg D
    Radiother Oncol; 2005 Dec; 77(3):310-7. PubMed ID: 16226818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
    Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of the distance of the rectal mucosa from a gynecologic afterloading applicator based on the drop in performance of a cobalt-60-source].
    Schrader R; Bahnsen J; Schrader D; Frischbier HJ
    Strahlenther Onkol; 1994 Feb; 170(2):103-6. PubMed ID: 8108775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.